Fig. 2: Fungal burden of kidneys in the case of commercial and clinical isolates of S. ‘boulardii’. | Communications Biology

Fig. 2: Fungal burden of kidneys in the case of commercial and clinical isolates of S. ‘boulardii’.

From: ENA1 deficiency attenuates Saccharomyces ‘boulardii’ probiotic yeast virulence in immunosuppressed mouse fungaemia model

Fig. 2: Fungal burden of kidneys in the case of commercial and clinical isolates of S. ‘boulardii’.The alternative text for this image may have been generated using AI.

An individual data point represents the kidney burden [CFU/kidney weight (g)] of an individual mouse. Data from mice that died during or were killed at the end of the experiment are both plotted. Horizontal black lines represent the median of the datapoints, whiskers extend to minimum and maximum values. Results of Kruskal–Wallis test with Bonferroni correction (α = 0.005) for the commercial and for the clinical isolates’ values are shown in bottom of the plot areas (n.s.: non-significant; *: p < 0.05). Number of mice used for the experiments was n = 9 (PY0001, PY0002, PY0004, DE27020, DE6507, DE35762), n = 8 (PY0003, 551/2018), and n = 7 (DE3912, DE42807, DE42533, DE45866, 465/2018, 2251/2018), as in Fig. 1.

Back to article page